Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center, Open-label Clinical Trial to Evaluate Pharmacokinetic Characteristics and Safety of PBK-1801 After Single Oral Administration in Healthy Korean Women Volunteers

NCT04418388 is registered in ClinicalTrials.gov with Pharmbio Korea Co., Ltd. as lead sponsor.

NCT NCT04418388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04418388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center, Open-label Clinical Trial to Evaluate Pharmacokinetic Characteristics and Safety of PBK-1801 After Single Oral Administration in Healthy Korean Women Volunteers
Lead sponsor
Pharmbio Korea Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
October 24, 2019
Completion date
December 23, 2019
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteer